UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026627
Receipt number R000030574
Scientific Title The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases
Date of disclosure of the study information 2017/05/16
Last modified on 2019/03/07 14:53:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

Acronym

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

Scientific Title

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

Scientific Title:Acronym

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope for detection of pancreatic diseases

Region

Japan


Condition

Condition

pancreatobiliary diseases

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and the safety of endoscopic ultrasonography using newly developed endoscope

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The efficacy and the safety of endoscopic ultrasonography using newly developed endoscope

Key secondary outcomes

The findings acquired from newly developed endoscope


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Screen pancreas and biliary tract using newly developed endoscope during upper gastrointestinal endoscopy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients of 50 years and upward who undergo upper gastrointestinal endoscopy

Key exclusion criteria

Performance status = 3 or 4
Organ failure
Screened pancreas within a half year
Without the consent
Postoperative digestive tract

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Okada

Organization

Okayama University Hospital

Division name

Gastroenterology

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama

TEL

086-235-7219

Email

hiro@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Daisuke Uchida

Organization

Okayama University Hospital

Division name

Gastroenterology

Zip code


Address

2-5-1, Shikata-cho, Kita-ku, Okayama

TEL

086-235-7219

Homepage URL


Email

d.uchida0309@gmail.com


Sponsor or person

Institute

Okayama University

Institute

Department

Personal name



Funding Source

Organization

Okayama University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Intraoperative hypotension occurred as an adverse event of intravenous anesthesia in one patient. There were 82 pancreaticobiliary findings and 165 upper-gastrointestinal findings (malignancy not included). Follicular lymphoma of intra-abdominal lymph nodes was detected in one patient. The mean imaging scores of each section were 1.95 (pancreatic head and papilla), 2.0 (pancreatic body), 1.99 (pancreatic tail), and 1.89 (common bile duct and gallbladder). Age, history of diabetes mellitus, and smoking history were associated with the prevalence of pancreatic diseases significantly.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 16 Day

Date of IRB


Anticipated trial start date

2017 Year 05 Month 16 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2018 Year 12 Month 31 Day

Date analysis concluded

2019 Year 03 Month 07 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 21 Day

Last modified on

2019 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030574


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name